Back to Alzheimers Disease
NCT00297414
NCT00297414
Who may be able to join
Who might be able to join this trial:
- You must have already taken part in one of three specific previous studies (known as CR003145, CR002014, or CR005947), where you were given either galantamine or a placebo (a dummy treatment).
Who may not be able to join:
- If you did not take part in any of the three studies mentioned above, you would not be eligible for this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Registry
clinicaltrials_gov
Start date
1 June 2004
Est. completion
1 January 2005
Where this trial is recruiting
🇦🇷 Argentina
🇦🇺 Australia
🇦🇹 Austria
🇧🇪 Belgium
🇨🇦 Canada
🇨🇿 Czechia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇱 Israel
🇳🇱 Netherlands
🇵🇱 Poland
🇪🇸 Spain
🇸🇪 Sweden
🇬🇧 United Kingdom
🇺🇸 United States
8 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
To evaluate vital status of patients enrolled in 3 galantamine studies
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.